New England Journal of Medicine published a clinical update in Research Highlights on 25 Mar 2026. The item focuses on Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer. Review the original article for the full source wording and details.
New England Journal of Medicine published a clinical update in Research Highlights on 25 Mar 2026.
The item focuses on Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer.
Review the original article for the full source wording and details.